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T-LYMPHOCYTE  PRECURSORS 
I.  Synergy Between Precursor and Mature T  Lymphocytes in 
the Response to Concanavalin A* 
BY J.  JOHN  COHEN  AND  SALLY  S.  FAIRCHILD 
(From the Departments of Microbiology  and Medicine, Box B-175 , University of Colorado Medical 
School, Denver, Colorado  80220) 
Thymus-derived  lymphocyte  precursors (pre-T cells) 1  are found in adult mam- 
malian bone marrow. The precursor nature of the cells can be demonstrated by 
their ability to reconstitute the thymus of irradiated recipients (1). This proce- 
dure is tedious, not easily quantitated, and only rarely applicable to humans. 
Fortunately, another assay for pre-T cells has recently been described: in the 
presence of certain "inducers," notably thymus humoral factors, pre-T cells 
rapidly express surface antigens characteristic of more mature, thymic cells (2). 
The number of such induced cells can be quantitated by a cytotoxic assay (2) or 
by immunofluorescence (3). Whether all pre-T cells are detected in this way is 
unknown. 
If pre-T-cell maturation is analogous to that of other hematopoietic precursor 
cells, there will be several maturation stages between the uncommitted  hemato- 
poietic stem cell and the final pre-T cell, that is, the cell that enters the thymus 
and begins the intrathymic differentiation  process. The assay using induction of 
surface markers is of limited use in distinguishing different maturation stages. 
We have been looking for functional markers of pre-T-cell maturation, and here 
report on a  novel property of certain pre-T cells:  the ability to enhance the 
response of mature T cells to the phytomitogen concanavalin A (Con A). 
Materials and Methods 
Mice.  Most experiments reported  here used male CBA/J mice obtained from The Jackson 
Laboratory, Bar Harbor, Maine. They were purchased at 5 wk of age and kept in our animal house 
at least 3 wk before use, to minimize possible stress-induced sequestration ofT cells in their bone 
marrow.  Male CBA/CaJ and CBA/H-T6J mice were also obtained from The Jackson Laboratory. 
Male AKR/J mice, 8-wk old, were a  gift of Dr.  P.  A. Campbell.  Nude (athymic) mice bred on a 
C57BL/6 background were also supplied by Dr. Campbell. 
Lymphocyte Preparations.  Bone marrow (BM) was flushed from tibias and femurs with Hanks' 
balanced salt  solution (HBSS), passed once through a 25-gauge needle, washed in HBSS, and 
resuspended in tissue culture medium (TCM) consisting of 5% fetal  calf  serum (Grand Island 
Biological  Co.,  Grand Island,  N. Y.,  lot  number 730703-the importance of  using  a selected  lot  will 
be discussed) in RPMI  1640 with 100 /~g/ml streptomycin  and 100 U/ml penicillin.  Cortisol- 
* Supported by U. S. Public Health Service Grants AI-11661 and AI-TI-00013. 
Abbreviations used in this  paper: BM, bone marrow; Con A, concanavalin A; CRT, cortisol- 
resistant  thymocytes; [3H]TdR, tritium-labeled  thymidine; HBSS, Hanks' balanced salt  solution; 
PHA, phytohemagglutinin; pre-T,  precursors of  T cells;  TCM, tissue  culture medium. 
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resistant  thymocytes (CRT) were prepared from the thymuses of  mice given 2.5  mg of  hydrocorti- 
sone acetate (Cortril,  Pfizer  Inc.,  New York) intraperitoneally  2 days previously.  The thymuses 
were  disrupted by  gentle  tapping  on  100-mesh  wire  screens,  and  the  cells  were  passed  once  through 
a 25-gauge needle, washed in HBSS, and resuspended in TCM. Cell suspensions were similarly 
prepared from normal lymph nodes and spleen.  Total nucleated cells  were counted on a hemocy- 
tometer. 
Peritoneal cells were obtained by washing the peritoneums of normal CBAJJ mice with 3 ml of 
HBSS; recovery was about 2  x  l0  ~ cells/mouse. 3T3 cells, harvested as they approached density- 
dependent  growth inhibition,  were kindly supplied by Dr.  John Lehman.  Glass-adherent  cells 
were prepared from spleen by the method of Mosier (4). 
Cells with surface immunoglobulin (Ig) were removed from bone marrow by passage through a 
column of polymetacrylate beads to which mouse Ig and rabbit anti-mouse Ig had been bound (5). 
Lymphocyte Cultures.  When it was intended to measure proliferation, cultures were set up in 
Microtest II plates  (Falcon Plastics,  Oxnard,  Calif.)  in a  total  vol of 200  /~1. In our standard 
conditions for demonstrating interactions, 6 x  10  s BM cells and 2 x  105 CRT cells were used, either 
separately  or mixed.  One set of triplicate cultures had  no further additions,  and Con A  (final 
concentration 2/~g/ml) was added to another set. The plates were incubated at 37°C in humidified 
5% CO2 in air for 48 h; 0.5  ~Ci of tritiated thymidine  ([3H]TdR,  Schwartz]Mann  Div., Becton, 
Dickinson & Co., Orangeburg, N. Y., 6.7 Ci/mM) were added 6 h before harvest. Incorporation of 
the  label  into  trichloroacetic  acid  insoluble  material  was  determined  by  liquid  scintillation 
counting. 
In some experiments blast transformation was determined. Aliquots of cultures were diluted in 
2% acetic acid and examined by phase contrast microscopy. Those cells with diameters at least 
thrice that of a small lymphocyte and with enlarged nuclei with visible nucleoli were counted as 
lymphoblasts.  Other aliquots were stained with (a) rabbit anti-mouse immunoglobulin labeled 
with fluorescein isothiocyanate (RAMIG-FITC, Behring Diagnostics, Inc., Woodbury, N. Y.), (b) 
anti-Thy-l.1,  followed by  RAMIG°FITC,  or (c)  anti-Thy-l.2,  followed by  RAMIG-FITC.  Cells 
bearing Thy-1 were enumerated by subtracting the percentage of cells labeled with RAMIG-FITC 
alone (B cells) from the percentage staining with anti-Thy-1 and RAMIG-FITC. This method has 
been described (3). 
Similar cultures were set up using CRT and BM from CBA/H-T6J and CBAJCa mice. After 48 h 
of culture 1/~g of colchicine was added per ml of culture, and 1.5 h  later the cells were swollen, 
fixed, and examined for metaphases by the method of Ford (6).  100 metaphases were counted in 
each mixture. 
Results 
Synergistic Responses of Lymphocyte Mixtures  to Con A.  BM  cells  at  a 
concentration of 6 x  105/well (3 x  10~/ml) respond poorly to Con A  (Table I). CRT 
at  2  x  105  cells/well  (10e/ml)  also  respond  poorly,  in  this  case  because  the 
concentration  of cells  is  suboptimal.  The  response  of CRT  is  variable  from 
experiment to experiment,  as can be seen in Tables I and IV. 
When BM and CRT are mixed in culture,  the response to Con A  is greatly 
enhanced (Table I). A "synergistic index" can be derived by dividing the observed 
uptake of [3H]TdR in the mixture -by the sum of the uptakes by BM and CRT 
incubated separately.  Indices of 3-40 have been observed.  Other cell mixtures 
also give synergistic responses. Table I lists several of these: spleen +  CRT, BM 
+  spleen,  BM  +  lymph node. 
Most of our studies have centered on the BM-CRT interaction.  We have found 
that the optimum concentration of Con A  (2 ~g/ml) is the same for the mixtures 
as  for the  separate  populations.  Similarly,  the  peak  response  is not shifted, 
being  on day  2  in this system.  The  optimal  proportions of BM to CRT were 
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TABLE  I 
Synergistic Responses  of Lymphoid Cell Mixtures to Con A 
Exp.  Cells  Cells/Well  Con A response  Additive  Synergistic 
x  10  -5  index* 
3a. 
3b. 
cpm 
BM  6  1,120} 
CRT  2  1,220 
BM +  CRT  6  +  2  17,600 
Spleen  6  45,800 
CRT  2  10,090/ 
Spleen +  CRT  6  +  2  190,200 
BM  6  4,370 
Spleen  1  2,820 ) 
BM +  spleen  6  +  1  20,840 
BM  6  4,370~ 
Lymph node  1  8,140 } 
BM +  lymph node  6  +  1  50,320 
2,340 
55,900 
7,200 
12,510 
7.5 
3.4 
2.9 
4.0 
* Con A response of mixture divided by sum of Con A  responses of individual members of 
mixture. 
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Fro.  1.  Response of 2 x  105 CRT to Con A  (stippled bar) and response of the same number 
of CRT  in the presence of variable numbers of BM cells  (upper curve).  The lower curve 
shows the response of BM cells alone. J.  JOHN  COHEN  AND  SALLY  S.  FAIRCHILD 
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FIG.  2.  Response to Con A  of variable numbers of CRT alone (lower curve) and in the 
presence of 2  ×  105 BM cells (upper curve). The response of 2  ×  105 BM cells alone is also 
shown (stippled bar). 
a  constant number  of CRT in the  presence of variable  numbers of BM cells. 
There is a sharp increase in [3H]TdR incorporation as the BM dose is increased 
from 0.25 to 1.0 ×  105 cells/well; the slope of a log:log plot of this part of the curve 
is  1.0.  After  a  plateau,  there  is  a  marked  decrease  in  synergy  at  high  BM 
concentrations.  Different  batches  of CRT  and  BM have  different  optima;  in 
general,  best synergy is seen with a  BM:CRT ratio of 1:1-3:1. 
Fig.  2  shows  typical  dose-response  curves  of CRT,  both  alone  and  in  the 
presence of a constant number (2 ×  105) of BM cells/well. The slope of log CRT 
number vs. log cpm is 2.2 for CRT alone (mean in seven experiments was 2.3 _+ 
0.22 standard error [SE]). Similarly plotted, the slope for CRT in the presence of 
constant BM was 0.9 (mean 0.83 _  0.05 SE). 
BM Induces CR T  to Respond to Con A.  The next series of experiments was 
carried out to determine which partner (BM or CRT) actually contributed most 
of the synergistic [3H]TdR uptake in the mixture.  BM and CRT were prepared 
from both CBA/Ca and  CBA/H-T6J mice,  mixed reciprocally,  and stimulated 
with Con A. Spreads of metaphase cells were examined at day 2 for normal and 
T6T6 karyotypes. Using T6T6 BM and  normal  CRT (Table II,  experiment  1), 
86%  of classifiable  metaphases  were of CRT type;  in  the  reciprocal  mixture, 
100% of classifiable metaphases were of CRT type. The difference between the 
two results is probably technical, it being easier to establish that a metaphase is 
T6T6 than that it is definitely not. Thus, on the average, 93% of the metaphases 
we could identify were of CRT origin. 
A  second  approach  to the  same question  involved mixing  CRT and  BM of 
AKR/J and CBA/J donors. These cells are matched at H-2 but differ at Thy-1. 
They  also  differ  at  the  M  locus,  but  in  our hands  give  no  detectable  MLC 
(probably due to the immaturity of BM and CRT and to a suboptimal incubation 
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TABLE  II 
Cells with T6/T6 and Normal Karyotypes  in Mixtures of CBA/H-T6 
and CBA/Ca Bone Marrow and Cortisol-Resistant  Thymocytes 
Metaphases 
Exp.  Bone marrow  CRT  Unclassi-  T6/T6  Normal  fled 
%  %  % 
1  T6/T6  Ca  12  71  17 
2  Ca  T6/T6  88  0  12 
TABLE  III 
Lymphoblasts Bearing Thy-1.1  and Thy-1.2 in Con A-Stimulated 
Cultures of BM and CRT from CBA/J and AKR/J Donors 
Synergistic Thy-l.1  Thy-l.2  Bone marrow  CRT  index* 
%  % 
CBA (Thy-l.2)  AKR (Thy-l.1)  11  92  4 
AKR  CBA  19  20  74 
* Total blasts/culture in mixtures divided by the sum of blastsjculture in 
separate BM and CRT cultures. 
markers;  surface Ig,  Thy-l.1,  and Thy-l.2 were  detected by immunofluores- 
cence.  From Table  III it can be  seen that there was  good synergy for blast 
transformation. No Ig-positive blasts were observed, and 94-96% of total blasts 
bore either Thy-l.1 or Thy-l.2. A mean of 83% of blasts were of CRT origin. 
What  is  the  "Stimulator"  Cell  in  BM?  The  following experiments  were 
designed to determine if a specific cell type in BM were responsible for inducing 
the enhanced response of  CRT to Con A. Since our first thought was that any cell 
might work, possibly by a feeder effect, we added contact-inhibited 3T3 cells to 
CRT. Not only was there no synergy, there was profound inhibition of [3H]TdR 
incorporation (Table IV). Similarly, neither normal peritoneal cells nor purified 
splenic adherent cells enhanced the response of CRT.  Thus the possibility of 
CRT being deficient in adherent cell function could be eliminated. 
BM contains considerable numbers of  B lymphocytes, which could conceivably 
be responsible for the synergy. To test this,  BM was run through an anti-Ig 
column (Table IV). The unprocessed BM contained 30% small lymphocytes, of 
which 20%  were  surface Ig positive.  The column-passed cells were  also 30% 
small lymphocytes; of these,  fewer than 0.5%  were Ig positive.  The column- 
passed (B depleted) BM synergized slightly better than did the unseparated BM, 
whose synergistic index was 6.3.  Nylon wool columns (7) also failed to remove 
the CRT-stimulating activity (data not shown, because the removal of B cells 
was incomplete). 
Although BM contains few T cells (that is, cells that are Thy-1 positive and 
post-thymic), it does contain some, and T-T interaction was a possible explana- 
tion of our results. Accordingly, BM and spleen from nude mice were mixed with 
CRT and synergy measured. Neither spleen nor BM responded significantly to 
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TABLE IV 
Different Cell Populations as Stimulators of Con A  Response of 2  x 105 Cortisol- 
Resistant Thymocytes 
Synergistic 
Exp.  Cell population  tested  CRT  Con A response  Additive  index 
cpm 
3T3 (6)*  0  50[ 
-  +  5,030  J 
+  +  90 
5,080  0.02 
2.  Peritoneal washings (6)  0  7,570~ 
-  +  i  5,890J 
+  +  5,600 
13,460  0.4 
3.  Adherent cells (3)  0  1,300~ 
-  +  10,900} 
+  +  10,300 
11,400  0.9 
4.  Anti-Ig column-passed BM 
(6)  0  O} 
-  +  890 
+  +  8,670 
890  9.7 
5a.  Nude bone marrow (6)  0  860~ 
-  +  0f 
+  +  5,040 
860  5.8 
5b.  Nude spleen (6)  0  610~ 
-  +  0~ 
+  +  35,780 
610  59 
* Number of cells/well  x 10  -'~. 
Studies  were  done  on the  T-cell precursor  content  of nude  BM  and  spleen. 
Suspensions of these cells were incubated overnight in TCM containing 200 ~g/ 
ml mouse thymosin,  fraction 3  (8),  or 2  ×  10  -5 M  8-(p-chlorophenyl)thiocyclic 
AMP. They were then stained with anti-Thy-l.2 by the indirect technique.  The 
results with both inducers were the same: 16% of the small lymphocytes in BM 
and 20%  in spleen became Thy-1 positive.  Since this BM contained  10% small 
lymphocytes and the spleen 80%, the overall pre-T content of BM was 1.6%, and 
of spleen,  16%.  The correlation with the  synergistic indices obtained with BM 
(5.8) and spleen  (59)  is striking. 
Is the Stimulating Cell in BM a Pre-T Cell?  We discovered fortuitously that 
BM incubated for 48 h  in TCM before mixing with CRT and Con A lost its ability 
to synergize.  We were thus able to see if we could add substances to maintain 
synergy.  In  Fig.  3  it  can  be  seen  that  thymosin  is  such  a  substance.  Other 
experiments,  not shown here,  have demonstrated  that 8-(p-chlorophenyl)thio- 
cyclic AMP will  also maintain the  synergistic ability of BM in vitro.  In both 
cases the BM cells were adjusted to 3  x  10  e cells/ml in TCM, and thymosin (final 
concentration  200  /~g/ml)  or  cyclic  AMP  (final  concentration  2.5  x  10  -~  M) 
added. After 48 h  of incubation the cells were washed twice, reconstituted to the 
original volume, and mixed with CRT in Microtest plates as described. 462  T-LYMPHOCYTE  PRECURSORS 
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FIG.  3.  Ability of 6  ×  105 BM cells to stimulate the Con A response of 2  ×  105 CRT. Bone 
marrow was used fresh or after 48-h incubation in TCM,  or TCM containing 200  ~g/ml 
thymosin. 
Discussion 
When CRT and BM cells are mixed and Con A added, a response is seen that 
is  much  greater  than  the  sum  of the  responses  of CRT  and  BM  cultured 
separately. This is true whether the response is measured by [3H]TdR incorpora- 
tion or by counting transformed lymphocytes. Although our standard mixture 
contains three times as many BM cells as CRT, the bulk of the response is by the 
CRT cells. This was established both with chromosomal markers (Table II) and 
with surface antigens  (Table III). These experiments showed that between 79 
and 100% of identifiable responding cells were of CRT origin; and Table III also 
shows that 94-96% of all responding cells bore the Thy-1 antigen.  We conclude, 
then, that when BM and CRT are mixed, the BM cells in some way enhance the 
response of T cells in CRT to Con A. 
A possible explanation is that CRT are deficient in macrophages (or macro- 
phage-like function),  since it has been shown that macrophages are necessary 
for lymphocytes to respond  well to mitogens  (9,  10).  However, added  macro- 
phages in the form of peritoneal washings or adherent cells (Table IV) failed to 
enhance the response of CRT to Con A. These experiments,  and the one using 
3T3 cells, also rule out the possibility that virtually any cell might stimulate 
CRT's response, possibly by presenting Con A to the T cells in a more efficient 
way. 
The interaction  of various numbers of CRT and BM cells is shown in Fig.  1 
and  2.  As few as  25  ×  103  BM cells cause  a  marked  increase  in the  Con A 
response of 2  x  105 CRT (synergistic index 2.4).  The curve is nearly linear  at 
lower  concentrations  of BM,  with  a  log:log  slope  of 1.0.  A  similar  slope  is 
obtained when the concentration of CRT is varied in the presence of a constant 
number of BM cells (Fig.  2); the slope of CRT alone is about 2.3. The simplest 
explanation of the change in slope is that a minimum of two cells interact when 
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The slope of 1.0 when CRT is titrated in the presence of BM might suggest a lack 
of cell-cell interaction; however, we think it more likely that this is an example 
of a  pseudo-first order process and really represents the  interaction  of two or 
more cells, only one of which (the responsive CRT cell) is now limiting.  What- 
ever the mechanism, it is clear that a given number of CRT respond to Con A far 
more vigorously in the presence of BM cells than in their absence. Whether this 
represents more cells being triggered  into cycle, or the same number of cells 
being triggered into more rapid cycle, remains to be determined. 
The phenomenon of synergy is not restricted to BM and CRT. Table I shows 
other combinations in which synergy has been observed. Thus, BM can syner- 
gize with spleen or lymph node. Using BM and spleen or lymph node from CBA 
and AKR mice in appropriate combinations, and staining the transformed cells 
as we did for BM-CRT mixtures, we have found that the majority of responding 
cells are T cells of spleen or lymph node origin in BM-spleen and BM-lymph node 
mixtures, respectively (unpublished). It appears that as a general principle, BM 
will induce mature T cells to respond to Con A better than they otherwise would. 
The nature of the cell in BM which interacts with mature T cells in the Con A 
response is of considerable interest.  We approached the question of its identity 
by a  process of elimination.  We have already discussed how we eliminated  a 
nonspecific trephocytic effect and the possibility that CRT is deficient in macro- 
phage  (adherent  cell) function.  The  B  cell was eliminated  as a  candidate  for 
synergizer because removal of B  cells on an anti-immunoglobulin  column did 
not diminish the BM's ability to synergize. Mature T cells were also eliminated 
by showing that nude BM or spleen could synergize with CRT, although neither 
contained detectable Thy-1 positive cells.  (Normal BM treated with anti-Thy-1 
serum  and  complement,  and  BM from  neonatally  thymectomized  mice,  also 
synergized with CRT; results not shown.) 
Having ruled out T cells, B cells, and macrophages as synergizers, we were 
left with lymphoid precursors and other hematopoietic cells as possibilities. Our 
further studies have implicated a precursor ofT cells. First, there is the striking 
correlation between content of pre-T cells in nude spleen and BM (as judged by 
the number of cells induced to express Thy-1 by thymosin) and their ability to 
stimulate  the  response  of CRT  to  Con  A.  This  evidence  is  circumstantial, 
however, and  requires independent  support,  which is provided by the type of 
experiment  shown in Fig.  3.  BM, which was capable of normal  synergy with 
CRT when fresh, lost virtually all this capacity after incubation for 48 h in TCM. 
If thymosin were added to the preincubation  medium,  however,  synergy was 
maintained  or enhanced.  A  similar maintenance  was obtained if the BM was 
preincubated  in  TCM  containing  2.5  ×  10  -5  M  8-(p-chlorophenyl)thio-cyclic 
AMP.  The  phosphodiesterase  inhibitor  RO20-1724  (12)  did  not maintain  the 
synergistic property. On the other hand, a B-cell function, the ability to respond 
to lipopolysaccharide, was enhanced by preincubation with RO20-1724 or cyclic 
AMP, but not by thymosin. 2 This is evidence for the pre-T-cell specificity of our 
thymosin and further support for the view that thymosin works by raising the 
intracellular  concentration  of cyclic AMP (13).  We believe these data indicate 
that there  is a  pre-T cell in BM and spleen which can interact with CRT and 
2 MacMillan, R. G., and J. J. Cohen. Manuscript in preparation. 464  T-LYMPHOCYTE  PRECURSORS 
other mature T cells in such a way that the T cells' response to Con A is greatly 
enhanced. This pre-T cell dies or becomes inactive on in vitro incubation unless 
it  is  maintained  by  thymic  hormone.  There  is  an  elegant  parallel  to  this 
hypothesis in studies of erythropoiesis.  Murine proerythroblasts rapidly die in 
culture,  unless incubated with erythropoietin,  which maintains  them and  in- 
duces hemoglobin formation (14); in other words, differentiation is necessary for 
survival of precursors in culture. 
The batch of fetal calf serum used in the TCM in which BM is preincubated is 
critical.  About half of the batches we have screened maintain  the synergistic 
ability of BM for 48 h as well as does thymosin. These batches have been shown 
to contain pre-T-cell inducer activity in a variety of other systems;  3 the activity 
may be due to thymus hormone itself. 
Interaction between subpopulations of T cells is a familiar concept in immu- 
nology, but to our knowledge this is the first reported interaction of T cells with 
precursors  of T  cells.  There  have  been several  systems described in which  a 
similar  phenomenon  may  have  taken  part.  Tridente  et  al.  (15)  found  that 
thymus and BM synergized for phytohemagglutinin  (PHA) response, but only if 
the thymus derived from new-born mice; the cell in BM which synergized was 
not a macrophage. Winkelstein et al. (16) found an increased response to PHA in 
thymus-BM mixtures,  but concluded that the increased response was contrib- 
uted by BM cells. We too have seen BM-CRT synergy in PHA responses, but it is 
much less than with Con A and works best at a BM:CRT ratio of approximately 
1:7 (unpublished results), while optimum for Con A  response is at a  BM:CRT 
ratio of from 1:1 to 3:1. These differences in magnitude and optimal proportions 
for Con A and PHA may be due to peculiarities of the culture system, or may 
reflect the fact that Con A and PHA seem to stimulate substantially separate T- 
cell populations (17). 
The availability of a new test for pre-T-cell function raises several interesting 
questions. We would like to know, for example, how the pre-T function we have 
described here relates to the pre-T cell which becomes Thy-1 positive on incuba- 
tion with thymic hormones (2, 3, 13), and to the pre-T cell which can repopulate 
an irradiated thymus (1). We would also be very interested to know if a similar 
pre-T cell exists in man and if a  similar test can be used to reveal it. A recent 
report by Delespesse  et  al.  (18)  describes striking  synergy between purified 
human T cells and what are described as B cells. We note, however, that 15-48% 
of cells in their B-cell fraction are unidentified; it is tempting to speculate that 
among them are pre-T cells which are the actual synergizers. Should this prove 
to  be  true,  it  would  mean  that  human  pre-T  cells  can  be  evaluated  by  a 
relatively simple technique, the application of which will extend our knowledge 
of normal  lymphopoiesis,  immunodeficiency  disease,  and  possibly lymphatic 
neoplasia. 
Summary 
When mouse bone marrow cells are mixed with cortisol-resistant thymocytes 
and stimulated in vitro with concanavalin A, the mitogenic response observed is 
much greater than  additive,  that is,  it is synergistic.  Between 94 and 96% of 
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responding cells could be identified as T  cells (Thy-1 positive) and of these,  79- 
100% derived from the cortisol-resisant thymocyte population, not from the bone 
marrow.  Purified  macrophages  could  not  replace  bone  marrow;  and  marrow 
depleted of mature T or B cells worked as well as normal marrow. Thus, T and B 
cells and macrophages were ruled out as the synergizing cell of bone marrow. 
Nude  spleen  contained  10  times  as  many  precursors  of T  cells  as  did  nude 
marrow and was 10 times better at synergy with cortisol-resistant thymocytes. 
This implication of the pre-T cell as synergizer was supported by the finding that 
the synergistic activity of marrow was lost on preincubation,  but maintained if 
the preincubation medium contained thymosin or cyclic AMP. Thus, the ability 
to enhance the response of relatively mature T cells to Con A is a property ofpre- 
T  cells. It is anticipated that this property will allow more detailed studies of T- 
cell precursor development in mice, and possibly in man. 
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